Narrative review / 2012
Oats may provide atheroprotective benefits through cholesterol reduction, antioxidant and anti-inflammatory properties, and endothelial function support.
This review summarizes evidence from in vitro, animal, and human studies on the antiatherogenic properties of dietary oats. Beyond lowering plasma total and LDL cholesterol via beta-glucans, oat micronutrients and phytochemicals may exert antioxidative and anti-inflammatory actions and help preserve endothelial function. The authors note that findings from in vitro assays using isolated components are hard to translate to whole oats, and highlight a lack of epidemiological studies examining oat intake across cardiovascular disease outcomes.
- Study type
- Narrative review
- Who was studied
- Not stated (in vitro, animal, and human studies)
- What was measured
- Atherogenic pathways, cholesterol levels, oxidation, inflammation, endothelial function
THE PAPER
Dietary oats and modulation of atherogenic pathways.
Andersson KE, Hellstrand P. Mol Nutr Food Res, 2012.
This note is written from the study's published abstract. It summarizes what the authors reported; it is not medical advice and does not replace reading the full paper.